Endothelin-1 releases eicosanoids from rabbit isolated perfused kidney and spleen. 1989

G A Rae, and M Trybulec, and G de Nucci, and J R Vane
William Harvey Research Institute, St. Bartholomew's Hospital Medical College, London, England.

This study analyzes the effects of porcine endothelin-1 (ET-1) on perfusion pressure and eicosanoid release from rabbit isolated spleen and kidney. Bolus injections (2.5-50 pmol) or infusions (1, 5, and 10 nM) of ET-1 into either organ caused dose-related increases of perfusion pressure. Pressor responses were potentiated following infusion of indomethacin (5.6 microM) for 30 min. ET-1 triggered the release of cyclo-oxygenase products as revealed by bioassay and radioimmunoassay (RIA) analysis of the effluent. In the spleen, ET-1 stimulated the release of PGE2 mainly and, to a lesser extent, of PGI2 and TXA2. In the kidney, ET-1 stimulated a greater release of PGI2 than PGE2, but not TXA2. These results demonstrate that in the isolated rabbit spleen and kidney, ET-1 is a potent vasoconstrictor and triggers the generation of vasodilator eicosanoids that limit the pressor effects of the peptide.

UI MeSH Term Description Entries
D007213 Indomethacin A non-steroidal anti-inflammatory agent (NSAID) that inhibits CYCLOOXYGENASE, which is necessary for the formation of PROSTAGLANDINS and other AUTACOIDS. It also inhibits the motility of POLYMORPHONUCLEAR LEUKOCYTES. Amuno,Indocid,Indocin,Indomet 140,Indometacin,Indomethacin Hydrochloride,Metindol,Osmosin
D007668 Kidney Body organ that filters blood for the secretion of URINE and that regulates ion concentrations. Kidneys
D008297 Male Males
D010455 Peptides Members of the class of compounds composed of AMINO ACIDS joined together by peptide bonds between adjacent amino acids into linear, branched or cyclical structures. OLIGOPEPTIDES are composed of approximately 2-12 amino acids. Polypeptides are composed of approximately 13 or more amino acids. PROTEINS are considered to be larger versions of peptides that can form into complex structures such as ENZYMES and RECEPTORS. Peptide,Polypeptide,Polypeptides
D010477 Perfusion Treatment process involving the injection of fluid into an organ or tissue. Perfusions
D011464 Epoprostenol A prostaglandin that is a powerful vasodilator and inhibits platelet aggregation. It is biosynthesized enzymatically from PROSTAGLANDIN ENDOPEROXIDES in human vascular tissue. The sodium salt has been also used to treat primary pulmonary hypertension (HYPERTENSION, PULMONARY). Prostacyclin,Prostaglandin I2,Epoprostanol,Epoprostenol Sodium,Epoprostenol Sodium Salt, (5Z,9alpha,11alpha,13E,15S)-Isomer,Flolan,Prostaglandin I(2),Veletri
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D004537 Eicosanoic Acids 20-carbon saturated monocarboxylic acids. Arachidic Acids,Acids, Arachidic,Acids, Eicosanoic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

G A Rae, and M Trybulec, and G de Nucci, and J R Vane
January 1993, Journal of cardiovascular pharmacology,
G A Rae, and M Trybulec, and G de Nucci, and J R Vane
November 1994, General pharmacology,
G A Rae, and M Trybulec, and G de Nucci, and J R Vane
January 1989, Journal of cardiovascular pharmacology,
G A Rae, and M Trybulec, and G de Nucci, and J R Vane
June 1992, Journal of applied physiology (Bethesda, Md. : 1985),
G A Rae, and M Trybulec, and G de Nucci, and J R Vane
January 1991, Journal of cardiovascular pharmacology,
G A Rae, and M Trybulec, and G de Nucci, and J R Vane
January 1998, Journal of cardiovascular pharmacology,
G A Rae, and M Trybulec, and G de Nucci, and J R Vane
October 1974, The Journal of surgical research,
G A Rae, and M Trybulec, and G de Nucci, and J R Vane
August 1995, European journal of pharmacology,
G A Rae, and M Trybulec, and G de Nucci, and J R Vane
June 1993, European journal of pharmacology,
G A Rae, and M Trybulec, and G de Nucci, and J R Vane
January 1980, New Istanbul contribution to clinical science,
Copied contents to your clipboard!